메뉴 건너뛰기




Volumn 99, Issue 6, 2007, Pages 1427-1431

Different prostate-specific antigen assays give different results on the same blood sample: An obstacle to recommending uniform limits for prostate biopsies

Author keywords

Assays; Prostate cancer; PSA; Variation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 34447310064     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06805.x     Document Type: Article
Times cited : (35)

References (23)
  • 1
    • 0032855594 scopus 로고    scopus 로고
    • Prostate specific antigen: A decade of discovery - What we have learned and where we are going
    • Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J Urol 1999 162 : 293 306
    • (1999) J Urol , vol.162 , pp. 293-306
    • Polascik, T.J.1    Oesterling, J.E.2    Partin, A.W.3
  • 2
    • 0026077430 scopus 로고
    • Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin
    • Lilja H, Christensson A, Dahlen U et al. Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin Chem 1991 37 : 1618 25
    • (1991) Clin Chem , vol.37 , pp. 1618-25
    • Lilja, H.1    Christensson, A.2    Dahlen, U.3
  • 3
    • 0026027671 scopus 로고
    • A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
    • Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991 51 : 222 6
    • (1991) Cancer Res , vol.51 , pp. 222-6
    • Stenman, U.H.1    Leinonen, J.2    Alfthan, H.3    Rannikko, S.4    Tuhkanen, K.5    Alfthan, O.6
  • 5
    • 0035729131 scopus 로고    scopus 로고
    • Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancer
    • Blijenberg BG, Yurdakul G, Van Zelst BD, Bangma CH, Wildhagen MF, Schroder FH. Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancer. BJU Int 2001 88 : 545 50
    • (2001) BJU Int , vol.88 , pp. 545-50
    • Blijenberg, B.G.1    Yurdakul, G.2    Van Zelst, B.D.3    Bangma, C.H.4    Wildhagen, M.F.5    Schroder, F.H.6
  • 6
    • 0030473107 scopus 로고    scopus 로고
    • Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen
    • Semjonow A, Oberpenning F, Brandt B, Zechel C, Brandau W, Hertle L. Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen. Urology 1996 48 (Suppl. 10 5
    • (1996) Urology , vol.48 , Issue.SUPPL. , pp. 10-5
    • Semjonow, A.1    Oberpenning, F.2    Brandt, B.3    Zechel, C.4    Brandau, W.5    Hertle, L.6
  • 7
    • 0032146613 scopus 로고    scopus 로고
    • Reference material for PSA: The IFCC standardization study. International Federation of Clinical Chemistry
    • Stamey TA, Chen Z, Prestigiacomo AF. Reference material for PSA: the IFCC standardization study. International Federation of Clinical Chemistry. Clin Biochem 1998 31 : 475 81
    • (1998) Clin Biochem , vol.31 , pp. 475-81
    • Stamey, T.A.1    Chen, Z.2    Prestigiacomo, A.F.3
  • 8
    • 0033816633 scopus 로고    scopus 로고
    • Reference reagents for prostate-specific antigen (PSA): Establishment of the first international standards for free PSA and PSA (90: 10)
    • Rafferty B, Rigsby P, Rose M, Stamey T, Gaines Das R. Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90: 10). Clin Chem 2000 46 : 1310 7
    • (2000) Clin Chem , vol.46 , pp. 1310-7
    • Rafferty, B.1    Rigsby, P.2    Rose, M.3    Stamey, T.4    Gaines Das, R.5
  • 9
    • 0034921199 scopus 로고    scopus 로고
    • Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?
    • Semjonow A, Oberpenning F, Weining C et al. Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer? Clin Chem 2001 47 : 1472 5
    • (2001) Clin Chem , vol.47 , pp. 1472-5
    • Semjonow, A.1    Oberpenning, F.2    Weining, C.3
  • 10
    • 0030339750 scopus 로고    scopus 로고
    • Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values
    • Semjonow A, Brandt B, Oberpenning F, Roth S, Hertle L. Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values. Prostate Suppl 1996 7 : 3 16
    • (1996) Prostate Suppl , vol.7 , pp. 3-16
    • Semjonow, A.1    Brandt, B.2    Oberpenning, F.3    Roth, S.4    Hertle, L.5
  • 11
    • 2442526439 scopus 로고    scopus 로고
    • Variation in prostate specific antigen results from 2 different assay platforms: Clinical impact on 2304 patients undergoing prostate cancer screening
    • Link RE, Shariat SF, Nguyen CV et al. Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening. J Urol 2004 171 : 2234 8
    • (2004) J Urol , vol.171 , pp. 2234-8
    • Link, R.E.1    Shariat, S.F.2    Nguyen, C.V.3
  • 12
    • 0034125518 scopus 로고    scopus 로고
    • A comparison of six commercial assays for total and free prostate specific antigen (PSA): The predictive value of the ratio of free to total PSA
    • Patel D, White PA, Milford WA. A comparison of six commercial assays for total and free prostate specific antigen (PSA): the predictive value of the ratio of free to total PSA. BJU Int 2000 85 : 686 9
    • (2000) BJU Int , vol.85 , pp. 686-9
    • Patel, D.1    White, P.A.2    Milford, W.A.3
  • 13
    • 33746633333 scopus 로고    scopus 로고
    • Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation
    • Kort SA, Martens F, Vanpoucke H, van Duijnhoven HL, Blankenstein MA. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. Clin Chem 2006 52 : 1568 74
    • (2006) Clin Chem , vol.52 , pp. 1568-74
    • Kort, S.A.1    Martens, F.2    Vanpoucke, H.3    Van Duijnhoven, H.L.4    Blankenstein, M.A.5
  • 14
    • 30844455114 scopus 로고    scopus 로고
    • Prostate-specific antigen: Bias and molarity of commercial assays for PSA in use in England
    • NHS Prostate Cancer Risk Management Programme.
    • Roddam AW, Rimmer J, Nickerson C, Ward AM NHS Prostate Cancer Risk Management Programme. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England. Ann Clin Biochem 2006 43 : 35 48
    • (2006) Ann Clin Biochem , vol.43 , pp. 35-48
    • Roddam, A.W.1    Rimmer, J.2    Nickerson, C.3    Ward, A.M.4
  • 15
    • 29744462375 scopus 로고    scopus 로고
    • Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: An update
    • Stephan C, Klaas M, Muller C, Schnorr D, Loening SA, Jung K. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update. Clin Chem 2006 52 : 59 64
    • (2006) Clin Chem , vol.52 , pp. 59-64
    • Stephan, C.1    Klaas, M.2    Muller, C.3    Schnorr, D.4    Loening, S.A.5    Jung, K.6
  • 16
    • 0029008314 scopus 로고
    • Software for illustrative presentation of basic clinical characteristics of laboratory tests - GraphROC for Windows
    • Kairisto V, Poola A. Software for illustrative presentation of basic clinical characteristics of laboratory tests - GraphROC for Windows. Scand J Clin Lab Invest Suppl 1995 222 : 43 60
    • (1995) Scand J Clin Lab Invest Suppl , vol.222 , pp. 43-60
    • Kairisto, V.1    Poola, A.2
  • 17
    • 0029951253 scopus 로고    scopus 로고
    • Analytical performance and clinical validity of two free prostate-specific antigen assays compared
    • Jung K, Stephan C, Lein M et al. Analytical performance and clinical validity of two free prostate-specific antigen assays compared. Clin Chem 1996 42 : 1026 33
    • (1996) Clin Chem , vol.42 , pp. 1026-33
    • Jung, K.1    Stephan, C.2    Lein, M.3
  • 19
    • 0032770605 scopus 로고    scopus 로고
    • Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51-4 ng/mL and digital rectal examination is not suspicious for prostate cancer: An alternative model
    • Catalona WJ, Partin AW, Finlay JA et al. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51-4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model. Urology 1999 54 : 220 4
    • (1999) Urology , vol.54 , pp. 220-4
    • Catalona, W.J.1    Partin, A.W.2    Finlay, J.A.3
  • 20
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter
    • Thompson IM, Pauler DK, Goodman PJ et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004 350 : 2239 46
    • (2004) N Engl J Med , vol.350 , pp. 2239-46
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3
  • 21
    • 0028256194 scopus 로고
    • Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men
    • Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 1994 151 : 1283 90
    • (1994) J Urol , vol.151 , pp. 1283-90
    • Catalona, W.J.1    Richie, J.P.2    Ahmann, F.R.3
  • 22
    • 33749512355 scopus 로고    scopus 로고
    • Ann Clin Biochem 2006; 43: 35-48
    • Accuracy assessment of PSA methods must be based on clinical instead of artificial samples - a response to AW Roddam*et al.
    • Stephan C, Semjonow A. Accuracy assessment of PSA methods must be based on clinical instead of artificial samples - a response to AW Roddam et al. Ann Clin Biochem 2006; 43: 35-48. Ann Clin Biochem 2006 43 : 421 2
    • (2006) Ann Clin Biochem , vol.43 , pp. 421-2
    • Stephan, C.1    Semjonow, A.2
  • 23
    • 0032550630 scopus 로고    scopus 로고
    • Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial
    • Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998 279 : 1542 7
    • (1998) JAMA , vol.279 , pp. 1542-7
    • Catalona, W.J.1    Partin, A.W.2    Slawin, K.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.